Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
about
Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004.Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells.Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trialsOutcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight.Chemotherapy dose in obese AML patients: to cap or not to cap?Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy.Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy.A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis.The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).A systematic review of treatment outcomes with weight-based dosing of chemotherapy in obese adult patients with acute leukemia or lymphoma.Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.Complex karyotype including ring chromosome 11 in a patient with acute myeloid leukemia: case report.Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.
P2860
Q33573539-D01E0EF9-A23D-4522-B81D-89A0BE2B7CB7Q33758623-3DDCCC52-8DAF-4976-878B-D55F90422CB4Q36494308-A8FFFADE-2D2C-4422-A0B1-FC8F2D6B680DQ36498580-CA795F84-E38A-499C-81A8-93B58593E397Q37506147-559DC2A7-97D4-478B-AC40-F62F7B9F767FQ37716294-F2DAEFB0-70AF-48BE-A470-5C338D1FCDA4Q41176272-64A4FA03-B4E8-4631-8F1E-62C86C5DCAF2Q41479185-548030CE-EEE2-4867-BFC4-FC6D5C076F98Q47095624-39BD2F97-9146-4B93-96D5-407F8169959DQ47174089-F1B0EF8D-2C45-45D3-B97F-30C4D2C63AA3Q47365368-0C8F92EF-7523-4C3E-8958-EFE0275F3805Q47570435-98DE64EC-B1AF-46BC-B9F4-B8AA30BAFCC4Q47661527-436BCBC2-AF12-45EB-A925-37A83240A17BQ48312577-4D34A68C-77B0-4D41-A2E9-21F1036D3D09
P2860
Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Outcomes in obese and overweig ...... cording to actual body weight.
@en
Outcomes in obese and overweig ...... cording to actual body weight.
@nl
type
label
Outcomes in obese and overweig ...... cording to actual body weight.
@en
Outcomes in obese and overweig ...... cording to actual body weight.
@nl
prefLabel
Outcomes in obese and overweig ...... cording to actual body weight.
@en
Outcomes in obese and overweig ...... cording to actual body weight.
@nl
P2093
P2860
P921
P356
P1476
Outcomes in obese and overweig ...... cording to actual body weight.
@en
P2093
Anjali S Advani
Candice M Wenzell
Erika M Gallagher
Jaroslaw P Maciejewski
Jun-Yen Yeh
Karissa N Kusick
Matt E Kalaycio
Mikkael A Sekeres
Ramon V Tiu
P2860
P304
P356
10.1002/AJH.23530
P577
2013-08-30T00:00:00Z